Specialty care that delivers more than medication
Discover how Evernorth helps consultants drive measurable value through integrated specialty pharmacy services.
From dispensing to delivering outcomes
With the help of Accredo and an Accredo nurse, patients can get treatment at home because every moment counts.
Specialty care is undergoing a meaningful transformation
What was once a transactional model focused solely on dispensing medications is now evolving into a comprehensive, patient-centered experience. Today’s specialty pharmacy must do more than deliver drugs—it must deliver outcomes. Evernorth’s specialty portfolio brings together pharmacy, medical, and behavioral health solutions to deliver whole-person care. Accredo® Specialty Pharmacy is the cornerstone of this ecosystem—offering high-touch, condition-specific support for patients with complex and rare diseases.
Providing personalized care to patients living with specialty conditions
Complex conditions can result in fragmented experiences
Patients with complex conditions often face fragmented experiences—navigating multiple vendors, unclear communication, and inconsistent care. Accredo addresses these challenges by integrating clinical oversight, patient education, and personalized support through the treatment journey.
With over 30 condition-specific Therapeutic Resource Centers (TRCs), Accredo provides personalized care from pharmacists, nurses, and social workers who specialize in the conditions they support. This model ensures better adherence, fewer complications, and improved outcomes.
What the data says about the future of specialty care
Evernorth client data and proprietary research fuels innovation across the specialty landscape—revealing trends, validating outcomes, and informing the solutions that drive better care and lower costs.
Neurological pipeline innovation
Breakthroughs in neurological care are accelerating, driven by a surge in targeted therapies, gene-based treatments, and precision medicine. Conditions like multiple sclerosis, ALS, and SMA are seeing new hope as the pipeline expands—yet the path to approval remains steep.
Read more
Adherence through multi-modal support
A recent study by Evernorth and Accredo of 14,552 patients showed that patients who received both digital and telephonic support were 1.8x more likely to achieve optimal adherence compared to those who received no support.1
Read more
EMR integration that accelerates care
EMR integration is transforming specialty pharmacy operations by streamlining workflows, reducing delays, and improving patient outcomes. Accredo’s EMR connectivity reduces prescription processing time by 2 days, improves gaps in care by 32%, and streamlines prior authorizations.2
Read more
Biosimilars are reshaping drug spend
Data from Evernorth Research Institute shows a reversal in inflammatory conditions drug trend—falling from 17.1% in 2019 to –1.9% in 2024, marking the first sustained reversal in drug trend for inflammatory conditions in years.3
Read more
Your partner in strategic specialty care
As part of Evernorth’s connected health services, Accredo delivers more than medication—it delivers results.
A high-touch, condition-specific model
Accredo empowers consultants to offer clients a specialty solution that improves adherence, reduces spend, and elevates the member experience.
$102M in specialty pharmacy savings, driven by therapy management protocols4
3.1M clinical and compliance interactions with patients in the last year5
11.8% higher adherence for patients in the oncology TRC using Accredo’s digital tools6
1M+ social determinants of health (SDOH) screenings delivered to Accredo patients7
Going beyond medication access
Evernorth partners with consultants to deliver cutting-edge specialty solutions that go beyond medication access—driving measurable outcomes, optimizing spend, and elevating the member experience. Whether you're looking to deepen your understanding of the evolving specialty landscape or explore how Accredo can support your clients’ goals, we’re here to help.
Sources
- Academy of Managed Care Pharmacy. April 2025; Houston, TX.
- Surescripts, How Accredo shaved 2 days off its turnaround time for specialty prescriptions. 2022.
- Evernorth Research Institute, Pharmacy in Focus, Biosimilars. 2025.
- 2024 Evernorth Specialty Data—Analytic & Reporting Consolidation.
- Accredo book of business data, 2024.
- Accredo cohort study, The use of digital tools and positive impact on patient adherence. 2024.
- Accredo book of business data, 2023-2024.
FOR CONSULTANT/BROKER USE ONLY. Please keep this information confidential and do not share outside of your firm.